Limited frequency of the CYP2C19*17 allele and its minor role in a Japanese population |
| |
Authors: | Sugimoto Katsuyoshi Uno Tsukasa Yamazaki Hiroshi Tateishi Tomonori |
| |
Affiliation: | Department of Clinical Pharmacology, Hirosaki University School of Medicine, Hirosaki, Aomori 036-8562, Japan and;Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Machida, Tokyo 194-8543, Japan |
| |
Abstract: | WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • A novel CYP2C19 gene variant, CYP2C19 * 17 , is associated with increased metabolic activity. • Ethnic differences in the frequency of the variant allele have been reported. However, the frequency of the CYP2C19 * 17 allele has not been studied in the Japanese population. WHAT THIS STUDY ADDS • In a population of 265 healthy Japanese subjects, a low frequency (1.3%) of the CYP2C19 * 17 allele was observed. • The limited frequency of the * 17 allele and the absence of a subject homozygous for * 17 indicated that CYP2C19 * 17 would play a minor role in a Japanese population. AIMS We investigated the CYP2C19 * 17 allelic frequency in Japanese subjects, and evaluated whether CYP2C19 * 17 is an important determinant of interindividual variability of CYP2C19 activity. METHODS We enrolled 265 subjects to determine their CYP2C19 genotype and plasma metabolic ratio following a single dose of 40 mg omeprazole. RESULTS Seven subjects heterozygous for CYP2C19 * 17 and no * 17/ * 17 subjects resulted in the CYP2C19 * 17 frequency being 1.3%. These heterozygotes had moderate metabolic activities when compared with the metabolic ratio of the other subjects. CONCLUSIONS The low frequency of CYP2C19 * 17 and the absence of * 17/ * 17 indicates that CYP2C19 * 17 plays a minor role in the Japanese population. |
| |
Keywords: | CYP2C19 genetic polymorphism Japanese |
本文献已被 PubMed 等数据库收录! |
|